Mylan gets South Africa contract for HIV meds; India's SRF buys DuPont's pharma propellant business;

> Mylan ($MYL) says its South Africa unit has gotten a three-year contract from the government there to manufacture antiretroviral (ARV) drugs for the country's treatment program. Release

> Baxter Healthcare ($BAX) is recalling 7,220 bags of an injectable product because of leaking bags. Recall

> Zydus Pharmaceuticals is recalling nearly 59,000 bottles of benzonatate, manufactured by its Cadila Healthcare operation Ahmedabad, India, because of leaking capsules. Recall

> American Health Packaging is recalling 3496 cartons of mercaptopurine tablets manufactured by San Diego, CA-based Prometheus Laboratories because the tablets failed dissolution tests. Recall

> Italian Medicines Agency pulls GMP certificate from Indian firm. Report

> India's SRF has acquired DuPont's ($DD) Dymel pharmaceutical propellant business for $20 million. Report

Suggested Articles

Gilead expects to sell 1 million to 1.5 million treatment courses of remdesivir in 2020. That means about $3.5 billion in sales, one analsyt figures.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Warp Speed's largest outlay to date, the funding will cover development and manufacturing scale-up of a vaccine that uses proven Sanofi technology.